The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
NeoFLOT II: Multicenter phase II study with short time neoadjuvant chemotherapy (stNACT) with 5-FU, FA, oxaliplatin, and docetaxel in rectable adenocarcinoma of the gastresophageal junction and gastric adenocarcinoma (T3, T4, and/or LN+) with high R0 resection rate over 91.5%.
 
Karsten Ridwelski
Consulting or Advisory Role - Amgen; Lilly; Merck KGaA
Speakers' Bureau - Merck KGaA
Travel, Accommodations, Expenses - Braun Travacare
 
Tobias Heina
No Relationships to Disclose
 
Joerg Fahlke
No Relationships to Disclose
 
Hendrik Kroening
No Relationships to Disclose
 
Walter Asperger
No Relationships to Disclose
 
Christoph Kahl
No Relationships to Disclose
 
Ulrich Halm
No Relationships to Disclose
 
Patrick Stuebs
No Relationships to Disclose
 
Carl Meissner
No Relationships to Disclose
 
Ronny Otto
No Relationships to Disclose
 
Kathrin Zierau
No Relationships to Disclose
 
Matthias Krueger
No Relationships to Disclose